Blog

With health benefit costs rising 5.8% in 2025, employers face their third straight year of increases above 5%, forcing tough decisions on coverage design and employee contributions.

With Medicare Advantage enrollment projected to reach 36.8 million beneficiaries in 2025, employers are rapidly shifting retiree healthcare strategies. Discover how this seismic change impacts your organization's benefits planning and bottom line.

President Trump's April 2025 executive order on healthcare price transparency mandates actual price disclosure and sets aggressive implementation deadlines. Learn how this impacts employer health plans, compliance requirements, and benefit strategies.

As Blue Cross Blue Shield and CVS Caremark restrict coverage for popular weight loss medications like Wegovy and Zepbound, employers face tough decisions about benefits design and employee health outcomes in 2025.

Health insurers deploy AI to slash prior authorization times by 85%, but rising denial rates and regulatory scrutiny signal major changes ahead for employers and brokers managing employee benefits.

Federal regulators announce sweeping requirements for health insurers to implement AI-driven prior authorization systems by 2026, promising to reduce delays and denials while saving employers billions in administrative costs.

Small employers confront their toughest benefits decision in years as health insurance premiums surge 9% for 2025, forcing many to consider dropping coverage entirely or dramatically restructuring benefits.

A bipartisan congressional proposal to cap the tax exclusion for employer-sponsored health insurance at $12,000 annually could fundamentally reshape how 160 million Americans receive healthcare coverage.

Blue Cross Blue Shield, CVS Caremark, and other major insurers are dramatically cutting coverage for popular weight loss medications like Ozempic and Wegovy, forcing employers to make tough decisions about employee benefits amid skyrocketing pharmaceutical costs.